# Echo Therapeutics, Inc.

Echo Therapeutics, Inc. is a company headquartered in Edgewater, NJ, United States.

## Company overview

- **Legal name:** Echo Therapeutics, Inc.
- **Former names in filing history:** SONTRA MEDICAL CORP (2002-07-03 to 2007-10-03); CHOICETEL COMMUNICATIONS INC/MN/ (2002-07-02 to 2002-07-01); CHOICETEL COMMUNICATIONS INC /MN/ (1997-11-12 to 2002-06-19)
- **Classification:** Company
- **Industry (SIC):** 3845 — Electromedical & Electrotherapeutic Apparatus
- **Headquarters:** Edgewater, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001031927

## About

Echo Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001031927, and its reported industry is Electromedical & Electrotherapeutic Apparatus. In 10-K filed on 2016-03-30, it reported annual revenue of USD 0; net income of USD -22,197,867; total assets of USD 805,090 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$22.2M (USD -22,197,867)
- **Total assets:** $805,090 (USD 805,090)
- **Cash and equivalents:** $56,210 (USD 56,210)
- **Operating cash flow:** -$5.1M (USD -5,079,864)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $57,321 (USD 57,321)
- **Net income:** -$15.0M (USD -14,962,654)
- **Total assets:** $12.6M (USD 12,595,836)
- **Cash and equivalents:** $1.3M (USD 1,278,941)
- **Operating cash flow:** -$10.7M (USD -10,724,603)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $27,600 (USD 27,600)
- **Net income:** -$19.1M (USD -19,067,397)
- **Total assets:** $23.1M (USD 23,089,295)
- **Cash and equivalents:** $8.1M (USD 8,055,385)
- **Operating cash flow:** -$19.4M (USD -19,409,836)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $5,119 (USD 5,119)
- **Net income:** -$12.3M (USD -12,332,008)
- **Total assets:** $20.0M (USD 20,021,592)
- **Cash and equivalents:** $3.7M (USD 3,747,210)
- **Operating cash flow:** -$10.3M (USD -10,287,665)

## Recent SEC filings

- Form 8-K — filed 2017-04-21 — period 2017-04-21 — PRIMARY DOCUMENT
- Form SC 13D — filed 2017-04-06 — PRIMARY DOCUMENT
- Form 8-K — filed 2017-03-22 — period 2017-03-21 — PRIMARY DOCUMENT
- Form 8-K — filed 2017-02-02 — period 2017-01-28 — FORM 8-K
- Form 8-K — filed 2016-12-27 — period 2016-12-21 — FORM 8-K
- Form 8-K — filed 2016-12-14 — period 2016-12-12 — FORM 8-K
- Form 8-K — filed 2016-12-02 — period 2016-12-02 — FORM 8-K
- Form 8-K — filed 2016-12-01 — period 2016-11-28 — FORM 8-K
- Form 8-K — filed 2016-11-23 — period 2016-11-18 — FORM 8-K
- Form 10-Q — filed 2016-11-16 — period 2016-09-30 — FORM 10-Q
- Form 8-K — filed 2016-10-19 — period 2016-10-19 — FORM 8-K
- Form 8-K — filed 2016-09-27 — period 2016-09-26 — PRIMARY DOCUMENT

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/echo-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology